BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7937788)

  • 1. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.
    Dietrich WF; Radany EH; Smith JS; Bishop JM; Hanahan D; Lander ES
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9451-5. PubMed ID: 7937788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
    Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma.
    Parangi S; Dietrich W; Christofori G; Lander ES; Hanahan D
    Cancer Res; 1995 Dec; 55(24):6071-6. PubMed ID: 8521395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
    Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
    Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
    Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
    Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.
    Lander JK; Fan H
    J Virol; 1997 May; 71(5):3940-52. PubMed ID: 9094671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.
    Guo SS; Arora C; Shimoide AT; Sawicki MP
    Mol Cell Endocrinol; 2002 Apr; 190(1-2):109-14. PubMed ID: 11997184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.
    Chung DC; Brown SB; Graeme-Cook F; Tillotson LG; Warshaw AL; Jensen RT; Arnold A
    Cancer Res; 1998 Aug; 58(16):3706-11. PubMed ID: 9721882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
    Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice.
    Cool M; Jolicoeur P
    Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
    Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
    Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
    Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.